HR-8883-119
Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 27 - 16.
Sponsored by Beth Van Duyne (R-TX)
What it does
This bill would strengthen federal oversight of hospice programs and home health agencies that participate in Medicare. It would require more frequent inspections for newly enrolled, recently sold, or high-risk providers; increase payment penalties for providers that fail to submit quality data (from 4% to 15% for hospices, and from 2% to 15% for home health agencies, starting in 2029); require re-screening of existing hospice providers in states already flagged for elevated fraud risk; mandate written notices to Medicare beneficiaries when they elect hospice care; and impose stricter standards on private accreditation organizations that certify these providers. The bill would transfer $100 million from the Medicare Hospital Insurance Trust Fund to fund increased survey activity, plus $6 million annually for beneficiary election notices.
Who benefits
Medicare beneficiaries (approximately 1.7 million hospice patients and 3.5 million home health patients annually) who would receive stronger protections against fraudulent or low-quality providers. Family members and caregivers of those patients who rely on accurate information about care elections. Legitimate, compliant hospice and home health providers who would face less competition from fraudulent operators. Taxpayers and the Medicare program broadly, if fraud is reduced. State survey agencies that may receive clearer standards relative to private accreditors. The HHS Inspector General's office, which gains a formal reporting relationship under the bill.
Who is hurt
Hospice programs and home health agencies — particularly smaller or newer ones — that would face increased administrative burdens, more frequent inspections, and higher financial penalties for data reporting failures. Providers in states already designated as high-risk would face mandatory re-enrollment screening. Providers that undergo ownership changes would face three years of annual surveys. Private accreditation organizations whose existing approvals could be revoked if they do not meet new training and procedural standards. The Medicare Hospital Insurance Trust Fund, which would absorb $100 million in implementation costs. Patients in areas with fewer providers may face reduced access if smaller agencies exit the market due to compliance costs.
Supporters argue
Supporters argue that Medicare hospice and home health fraud is a documented, large-scale problem: the HHS Office of Inspector General has repeatedly found that hospice providers bill for patients who are not terminally ill and that home health agencies enroll beneficiaries who do not qualify for services, costing Medicare billions annually. They contend that the current survey cycle — which can leave providers uninspected for years — creates gaps that bad actors exploit, and that raising the quality-data penalty from 4% to 15% is necessary to make non-compliance financially untenable. Supporters also argue that the beneficiary election notice requirement directly addresses a documented vulnerability in which patients are enrolled in hospice without their full understanding, forfeiting other Medicare benefits.
Opponents argue
Opponents argue that dramatically increasing inspection frequency and tripling financial penalties will impose disproportionate costs on small, rural, and nonprofit providers that already operate on thin margins, potentially driving them out of the market and reducing access to end-of-life care in underserved areas. They contend that the bill's broad delegation to the Secretary of HHS to define "aberrant behavior" and "extreme risk of fraud" gives the executive branch wide discretion to target providers without clear statutory standards, raising due process concerns. Critics also argue that the $100 million funding transfer from the Hospital Insurance Trust Fund — already projected to face long-term solvency pressure — adds financial strain to a program that serves all Medicare beneficiaries, not just those in hospice or home health.
Constitutional context
Congress has broad authority to set conditions on Medicare participation under the Taxing and Spending Clause (Art. I, §8, cl. 1), and providers voluntarily accept these conditions by enrolling in the program. No active constitutional tension is raised by this bill's core provisions. However, post-Loper Bright (2024), the bill's broad delegations to the HHS Secretary — particularly to define "aberrant behavior" and "extreme risk of fraud" — would face independent judicial scrutiny rather than automatic deference if challenged, meaning courts would assess whether the statutory language provides sufficient guidance.
Checks and balances
The executive branch (HHS/CMS) gains significant new administrative authority to define fraud risk criteria, set survey schedules, and revoke accreditor approvals; Congress checks this through a mandatory 5-year annual reporting requirement and retains authority to modify the statutory standards.
Historical precedent
The Improving Medicare Post-Acute Care Transformation (IMPACT) Act of 2014 similarly expanded quality data reporting requirements and oversight mechanisms for post-acute care providers, including home health agencies, and is directly referenced in this bill's funding provision.